|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Genetics, Case Comprehensive Cancer Centre, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio 44106, USA; 2 Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520, USA; 3 Institute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland; 4 Department of Radiation Biology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, California 91010, USA; 5 Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA; 6 Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
Members of the RecQ helicase family play critical roles in genome maintenance. There are five RecQ homologs in mammals, and defects in three of these (BLM, WRN, and RECQL4) give rise to cancer predisposition syndromes in humans. RECQL and RECQL5 have not been associated with a human disease. Here we show that deletion of Recql5 in mice results in cancer susceptibility. Recql5-deficient cells exhibit elevated frequencies of spontaneous DNA double-strand breaks and homologous recombination (HR) as scored using a reporter that harbors a direct repeat, and are prone to gross chromosomal rearrangements in response to replication stress. To understand how RECQL5 regulates HR, we use purified proteins to demonstrate that human RECQL5 binds the Rad51 recombinase and inhibits Rad51-mediated D-loop formation. By biochemical means and electron microscopy, we show that RECQL5 displaces Rad51 from single-stranded DNA (ssDNA) in a reaction that requires ATP hydrolysis and RPA. Together, our results identify RECQL5 as an important tumor suppressor that may act by preventing inappropriate HR events via Rad51 presynaptic filament disruption.
[Keywords: Recql5 helicase; DNA repair; homologous recombination; tumor suppressor; Rad51 recombinase]]
Received August 27, 2007; revised version accepted September 27, 2007.
8 Present addresses: Dana-Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, MA 02115, USA;
9 Department of Genetics and Biochemistry, Clemson University, Clemson, SC 29634, USA.
E-MAIL Patrick.Sung{at}yale.edu; FAX (203) 785-6404.
11 E-MAIL guangbin.luo{at}case.edu; FAX (216) 368-3432.
Supplemental material is available at http://www.genesdev.org.
Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.1609107
Related Articles
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Genes & Dev. 2007 21: 3019-3026.
Genes & Dev. 2007 21: 3085-3094.
This article has been cited by other articles:
![]() |
D. V. Bugreev, R. M. Brosh Jr., and A. V. Mazin RECQ1 Possesses DNA Branch Migration Activity J. Biol. Chem., July 18, 2008; 283(29): 20231 - 20242. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Aygun, J. Svejstrup, and Y. Liu A RECQ5-RNA polymerase II association identified by targeted proteomic analysis of human chromatin PNAS, June 24, 2008; 105(25): 8580 - 8584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Raynard, W. Zhao, W. Bussen, L. Lu, Y.-Y. Ding, V. Busygina, A. R. Meetei, and P. Sung Functional Role of BLAP75 in BLM-Topoisomerase III{alpha}-dependent Holliday Junction Processing J. Biol. Chem., June 6, 2008; 283(23): 15701 - 15708. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Branzei and M. Foiani RecQ helicases queuing with Srs2 to disrupt Rad51 filaments and suppress recombination Genes & Dev., December 1, 2007; 21(23): 3019 - 3026. [Full Text] [PDF] |
||||
![]() |
D. V. Bugreev, X. Yu, E. H. Egelman, and A. V. Mazin Novel pro- and anti-recombination activities of the Bloom's syndrome helicase Genes & Dev., December 1, 2007; 21(23): 3085 - 3094. [Abstract] [Full Text] [PDF] |
||||